Fante already fronts the company's commercial operations in North America. He will now also take on Central and South American responsibilities.
"Rich is a strong leader who will enable our company to successfully navigate the challenges facing our industry while delivering innovation and value to our customers, patients and shareholders," said Tony Zook, executive VP, global commercial operations.
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...
Who's in, who's out: all the latest changes in senior pharmaceutical appointments.